QAEM SHAHR, IRAN - APRIL 10: Volunteers in protective suits bury the body of a COVID-19 victim on April 10, 2020 in Qaem Shahr, Iran. The Coronavirus (COVID-19) pandemic has spread to many countries across the world, claiming over 100,000 lives and infecting over 1.8 million people. There have been over 4,000 deaths and over 70,000 people infected with the coronavirus (COVID-19) in Iran so far. (Photo by Majid Saeedi/Getty Images)
Over a year into the pandemic, you likely already know that recovering from a case of COVID typically confers some level of protection in the months following. Yet, as a team of French researchers from the Institut Pasteur and the Vaccine Research Institute (VRI) at University Paris-Est Créteil have pointed out, the exact nature of this protection has, until now, been “poorly characterized.”
They say that data has been especially lacking surrounding asymptomatic COVID cases, which they estimate may account for nearly half of all infections. Because of this, many patients who had mild COVID cases are in the dark as to whether they’re protected after recovery.That’s why the team set out to shed light on the level of protection following infections without symptoms, sharing their findings in the journal Cell Reports Medicine last week. They confirmed that asymptomatic infections leave behind an important type of antibody—a finding that could change how we understand immunity in asymptomatic cases. Read on to find out what they discovered, and for more on protection against COVID, This One Vaccine May Protect You Against All Variants, New Study Says.Read the original article on Best Life.